Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2007;11(4):161.
doi: 10.1186/cc6097.

Factor VII and the brain: time to get this research done!

Richard P Dutton
Editorial

Factor VII and the brain: time to get this research done!

Richard P Dutton. Crit Care. 2007.

Abstract

Traumatic brain injury is the leading killer after trauma, in part because of coagulopathy. Factor VIIa may be a useful therapy in this setting, depending on the relative risk for thromboembolic complications. Kluger and coworkers recently conducted a retrospective review of patients with traumatic brain injury from a previous factor VIIa and trauma trial. It documents an encouragingly low rate of complications, and should provide a strong incentive to conduct a prospective study of factor VIIa in patients with severe traumatic brain injury.

PubMed Disclaimer

Comment on

References

    1. Kluger Y, Riou B, Rossaint R, Rizoli SB, Boffard KD, Choong PI, Warren B, Tillinger M. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial. Crit Care. 2007;11:R85. doi: 10.1186/cc6092. - DOI - PMC - PubMed
    1. Dutton RP, Stein DM. The use of factor VIIa in haemorrhagic shock and intracerebral bleeding. Injury. 2006;37:1172–1177. doi: 10.1016/j.injury.2006.09.001. - DOI - PubMed
    1. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777–785. doi: 10.1056/NEJMoa042991. - DOI - PubMed
    1. Thomas GOR, Dutton RP, Hemlock B, Stein DM, Hyder M, Shere-Wolfe R, Hess JR, Scalea TM. Thromboembolic complications associated with FVIIa administration. J Trauma. 2007;62:564–569. - PubMed

LinkOut - more resources